The impact of bariatric and metabolic surgery on the morbidity and mortality of patients infected during the COVID-19 pandemic: a retrospective cohort study.
Luiz Henrique Sala de Melo CostaLuiz Filipe Sala de Melo CostaGabriela Rezende KachanJoão Kleber de Almeida GentileRaul Andrade Mendonça FilhoMarcela Ralin de Carvalho Deda CostaJurandir Marcondes Ribas-FilhoPublished in: Sao Paulo medical journal = Revista paulista de medicina (2022)
Bariatric surgery has a protective effect against severe COVID-19 in the obese population, bringing the prevalence of severe disease cases to levels equivalent to those of the nonobese general population, with a positive impact on morbidity and mortality.
Keyphrases
- weight loss
- bariatric surgery
- end stage renal disease
- coronavirus disease
- sars cov
- newly diagnosed
- obese patients
- early onset
- minimally invasive
- metabolic syndrome
- type diabetes
- adipose tissue
- roux en y gastric bypass
- peritoneal dialysis
- patient reported outcomes
- coronary artery bypass
- drug induced
- gastric bypass
- patient reported
- percutaneous coronary intervention